Suchergebnisse - "Buti, Maria"

PubPharm (7)

1

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

enthalten in: The Journal of infectious diseases | 2021

von Hsu, Y. | Yeh, M. | Wong, G. | +27

2

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy : a prespecified follow-up analysis of two randomised trials

enthalten in: The lancet. Gastroenterology & hepatology | 2019

von Buti, M. | Wong, D. | Gane, E. | +11

CommentIn: Lancet Gastroenterol Hepatol. 2019 Apr;4(4):260-262. - PMID 30795959

3

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

enthalten in: Journal of hepatology | 2018

von Agarwal, K. | Brunetto, M. | Seto, W. | +28

4

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2017

von Jacobson, I. | Washington, M. | Buti, M. | +13

5

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

enthalten in: Hepatology international | 2015

von Buti, M. | Fung, S. | Gane, E. | +12

6

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

enthalten in: Journal of hepatology | 2014

von Marcellin, P. | Buti, M. | Krastev, Z. | +14

7

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

enthalten in: The New England journal of medicine | 2008

von Marcellin, P. | Heathcote, E. | Buti, M. | +22

CommentIn: N Engl J Med. 2008 Dec 4;359(23):2488-91. - PMID 19052131

1
[1]